DHINGRA, Kapil,HIGGINS, Brian,KOLINSKY, Kenneth,LEE, Richard J.,LESTINI, Brian,PACKMAN, Kathryn E.,SU, Fei
申请号：
HUE11749393
公开号：
HUE025187T2
申请日:
2011.08.16
申请国别(地区):
HU
年份:
2016
代理人:
摘要：
The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer.
